For the full Person Specification and more information regarding the main responsibilities of this role, please refer to the attached Job Description. Please note, due to anticipated high volumes of applications, this vacancy may close earlier than the listed closing date. You are advised not to delay submitting your completed application Come and be a part of the best NHS trust in England to work for, according to our staff* * UCLH top trust to work at in England - In the most recent NHS staff survey UCLH had the highest percentage of staff who said they would recommend us as a place to work, out of all general acute or acute/community NHS trusts in England for the third year in a row. UCLH recognises the benefits of flexible working for staff To find out more, visit: Flexible working. To discover more about what makes UCLH a great place to work, visit: Why Choose UCLH? Key aims include the study of coronavirus infection to develop understanding of the dynamics of pandemics such as Covid-19. Legacy utilises a unique bank of clinical samples gathered as part of the Crick Institutes COVID-19 testing facility providing a remarkable resource for the investigation of facets of COVID-19 including immunity against emerging SARS-CoV-2 Variants of Concern (Wall et al., Lancet, 2021a; Wall et al., Lancet, 2021b), disease progression (Townsley et al., medRxiv, 2022), the impact of prior infection on immunity (Wu et al., Lancet, 2022a) vaccine efficacy and vulnerability of populations such as healthcare workers that can be used to inform policy on health and safety. Legacy also directly interfaces with other UCLH COVID studies examining the effect of the pandemic on different patient groups, including the NIHR funded STIMULATE-ICP trial. STIMULATE-ICP a large multi-centre trial investigating the symptoms, trajectory and pathogenesis of Long COVID in patients with persistent symptoms >12 weeks after primary COVID-19 infection. The causes of Long COVID remain unknown, and over 2 million people in the UK are estimated to be affected over the last 3 years. The post holder will undertake clinical work in the Post-COVID clinic at UCLH, and work on a reverse translational sub-study within the trial at the Francis Crick Institute, to test hypotheses on the causes of Long COVID and examining the immunological phenotypes underpinning a range of COVID-19 symptoms.